CVE-2022-26237
Beckman Coulter Remisol Advance Privilege Escalation Vulnerability
Description
The default privileges for the running service Normand Viewer Service in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.
INFO
Published Date :
Oct. 6, 2022, 6:15 p.m.
Last Modified :
Nov. 21, 2024, 6:53 a.m.
Source :
[email protected]
Remotely Exploitable :
No
Impact Score :
3.6
Exploitability Score :
1.8
Affected Products
The following products are affected by CVE-2022-26237
vulnerability.
Even if cvefeed.io is aware of the exact versions of the
products
that
are
affected, the information is not represented in the table below.
References to Advisories, Solutions, and Tools
Here, you will find a curated list of external links that provide in-depth
information, practical solutions, and valuable tools related to
CVE-2022-26237.
| URL | Resource |
|---|---|
| https://pastebin.com/DREqM7AT | Third Party Advisory |
| https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance | Product |
| https://pastebin.com/DREqM7AT | Third Party Advisory |
| https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance | Product |
We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).
Results are limited to the first 15 repositories due to potential performance issues.
The following list is the news that have been mention
CVE-2022-26237 vulnerability anywhere in the article.
The following table lists the changes that have been made to the
CVE-2022-26237 vulnerability over time.
Vulnerability history details can be useful for understanding the evolution of a vulnerability, and for identifying the most recent changes that may impact the vulnerability's severity, exploitability, or other characteristics.
-
CVE Modified by af854a3a-2127-422b-91ae-364da2661108
Nov. 21, 2024
Action Type Old Value New Value Added Reference https://pastebin.com/DREqM7AT Added Reference https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance -
CVE Modified by [email protected]
May. 14, 2024
Action Type Old Value New Value -
Initial Analysis by [email protected]
Oct. 10, 2022
Action Type Old Value New Value Added CVSS V3.1 NIST AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N Changed Reference Type https://pastebin.com/DREqM7AT No Types Assigned https://pastebin.com/DREqM7AT Third Party Advisory Changed Reference Type https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance No Types Assigned https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance Product Added CWE NIST CWE-732 Added CPE Configuration AND OR *cpe:2.3:a:beckmancoulter:remisol_advance:*:*:*:*:*:*:*:* versions up to (including) 2.0.12.1 OR cpe:2.3:o:microsoft:windows:-:*:*:*:*:*:*:*
CWE - Common Weakness Enumeration
While CVE identifies
specific instances of vulnerabilities, CWE categorizes the common flaws or
weaknesses that can lead to vulnerabilities. CVE-2022-26237 is
associated with the following CWEs:
Common Attack Pattern Enumeration and Classification (CAPEC)
Common Attack Pattern Enumeration and Classification
(CAPEC)
stores attack patterns, which are descriptions of the common attributes and
approaches employed by adversaries to exploit the CVE-2022-26237
weaknesses.
Exploit Prediction
EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days.
0.04 }} 0.00%
score
0.11742
percentile